JBIO Performance — Defiance Nasdaq Junior Biotechnology ETF
Data updated: 2021-11-29
JBIO returned +12.47% over one year to Sep 2021. Over one year the fund trailed its Global Health Care Equity category average: $100 grew to $112, against $115 for the category. Volatility over the past 12 months was 26.93% a year. In the 12 months to Sep 2021 the fund took in a net $8.0M, and assets reached $7.25M.
JBIO Growth of $100
What $100 invested in Defiance Nasdaq Junior Biotechnology ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Health Care Equity category average over the same months.
| Period | JBIO | Category average |
|---|---|---|
| 1 year (Oct 2020 – Sep 2021) | $112 | $115 |
| Since data start (Aug 2020 – Sep 2021) | $117 | $121 |
JBIO Trailing Returns
Total returns to Sep 2021, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +12.47% |
JBIO Annual Returns
Calendar-year total returns of Defiance Nasdaq Junior Biotechnology ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2021 (Jan–Sep) | −15.78% |
| 2020 (Aug–Dec) | +38.90% |
JBIO Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +3.9% | +0.6% | −7.8% | −0.8% | −6.2% | +6.8% | −10.1% | +4.5% | −6.4% | — | — | — |
| 2020 | — | — | — | — | — | — | — | +1.5% | +2.5% | +5.0% | +14.6% | +11.0% |
JBIO Risk
Risk measures from monthly returns over Oct 2020 – Sep 2021.
- 1-year volatility (annualised): 26.93%
- Best month: +14.62% (Nov 2020)
- Worst month: −10.09% (Jul 2021)
JBIO Fund Flows
Monthly money in and out of Defiance Nasdaq Junior Biotechnology ETF, from SEC Form N-PORT.
- 12-month net flow: $8.0M
- 12-month gross sales (incl. reinvestments): $6.2M
- Sales ÷ redemptions: -3.55×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Sep 2021 | $0 | $0 | $0 |
| Aug 2021 | $0 | $0 | $0 |
| Jul 2021 | $0 | $0 | $0 |
| Jun 2021 | $0 | $0 | $0 |
| May 2021 | $0 | $0 | $0 |
| Apr 2021 | $0 | $0 | $0 |
| Mar 2021 | $0 | $0 | $0 |
| Feb 2021 | $0 | $0 | $0 |
| Jan 2021 | $0 | $0 | $0 |
| Dec 2020 | $3.5M | −$1.8M | $5.3M |
| Nov 2020 | $0 | $0 | $0 |
| Oct 2020 | $2.7M | $0 | $2.7M |
JBIO Assets Under Management
Net assets of Defiance Nasdaq Junior Biotechnology ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2021-09-30 | $7.25M |
| 2021-06-30 | $8.24M |
| 2021-03-31 | $8.30M |
| 2020-12-31 | $8.61M |
| 2020-09-30 | $2.60M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.